VANGUARD ANALYTICS LTD

Company number 16178800 ·

Dissolved

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

VANGUARD ANALYTICS LTD - Analysis Report

Company Number: 16178800

Analysis Date: 2025-07-29 17:51 UTC

Financial Health Assessment for VANGUARD ANALYTICS LTD


1. Financial Health Score: B

Explanation:
VANGUARD ANALYTICS LTD demonstrates a sound early-stage financial position with positive net assets and healthy liquidity. However, as a newly incorporated company with a short trading period, its financial data is limited, so caution is warranted when projecting long-term stability. The absence of debt and positive working capital are promising, but growth and profitability metrics are not yet established.


2. Key Vital Signs

Metric Value (£) Interpretation
Cash at bank 21,778 Healthy cash balance indicating good liquidity for operational needs.
Current Liabilities 4,453 Low short-term obligations, manageable with existing cash.
Net Current Assets 17,325 (Current Assets - Current Liabilities) Positive working capital shows the company can meet short-term obligations.
Net Assets / Shareholders’ Funds 17,325 Positive equity base; company is solvent and not reliant on external financing yet.
Share Capital 1 Nominal capital reflecting start-up phase; majority equity in retained earnings.
Staff Numbers 1 (Director) Minimal staffing consistent with start-up or micro business status.
Company Age ~6 months Very young company; financial history is limited, which can mask volatility or potential future issues.
Audit Status Exempt Small company exemption means accounts are unaudited; less external assurance.

3. Diagnosis

VANGUARD ANALYTICS LTD presents the symptoms of a healthy start-up. The company has a positive cash buffer and a low level of current liabilities, indicating a healthy cash flow "pulse" and no immediate financial distress. The net asset position is positive, suggesting the company is solvent with adequate "financial reserves."

However, the company's infancy means there is no track record of profitability, revenue growth, or operational scalability. The single shareholder/director structure with 100% control by Mr. Hashim Peruaze Malik implies centralized management but also potential dependency risk on one individual.

The financial statements are prepared under small company exemptions and are unaudited, which is typical but means the data should be monitored closely as the business evolves.


4. Recommendations

To support and improve financial wellness, the company should consider the following actions:

  • Maintain robust cash management: Keep a close eye on cash flow to ensure liquidity remains strong as operations ramp up.
  • Build financial history: Establish regular accounting and financial reporting routines to enable detailed profitability and performance analysis.
  • Plan for growth capital: As the company grows, consider the need for investment to finance expansion, including potential equity or debt funding.
  • Risk diversification: Avoid over-reliance on a single director; consider expanding management or advisory support.
  • Compliance and governance: Continue timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.
  • Audit consideration: As turnover and size grow, prepare for audit requirements to enhance credibility with stakeholders.
  • Develop revenue streams: Focus on building customer base and contracts to transition from start-up phase to sustainable operations.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.